CDT Equity Sets Nov 12 Vote on J.J. Astor Note Conversion and Reverse Split
CDT sits 23% above its 52-week low of $0.181 on elevated volume (15× avg).
Summary
CDT Equity scheduled a November 12 special meeting for shareholders to approve the J.J. Astor convertible note share issuance and a reverse stock split of up to 1-for-1,000. The note's variable conversion price and the split's role as a default trigger make the vote critical to the company's financing and Nasdaq listing.
Key Events · Financing and Capital Events · CDT
-
Special Meeting Set for November 12
Shareholders of record as of October 23, 2026 will vote on the J.J. Astor note share issuance and a reverse stock split.
-
Note Conversion Could Issue 20%+ of Shares
The October Note converts at 70% of the lowest 20-day closing price with a $0.18354 floor; warrants for 373,220 shares are also exercisable.
-
Reverse Split Required by Note Terms
The October Note requires a split at a ratio targeting at least $5.00 per share if the bid stays below $1.00 for five days; failure to maintain that authority is an immediate event of default.
-
Second Tranche Conditioned on Approval
The $2.0M second tranche of the October Note is subject to stockholder approval, an effective resale registration, and a $3.00 minimum bid price for five days before closing.
Analysis · CDT · Life Sciences
Shareholders are being asked to approve the issuance of shares underlying the October Note and related warrants to J.J. Astor, plus a reverse stock split of up to 1-for-1,000. The October Note carries a conversion price of 70% of the lowest closing price over the prior 20 trading days, with a $0.18354 floor that resets lower every six months — a structure that can flood the market with shares as the price falls. In practice, the reverse split is not optional: the note requires the company to split if the bid stays below $1.00 for five days, and failure to maintain that authority is an immediate event of default. With cash of just $747K as of the last 10-Q and a $6.75M note funding in tranches, the vote is a survival condition for the company.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 45.2% of the 299 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.26%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CDT was trading at $0.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $264.4K. The 52-week trading range was $0.18 to $28,125.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.